Skip to main content
. 2012 May 28;18(20):2517–2525. doi: 10.3748/wjg.v18.i20.2517

Table 1.

Baseline characteristics

Variable Overall
Excluding patients with severe constipation
P value
A (mosapride) B (placebo) C (mosapride) D (placebo) A vs B C vs D
No. of patients 124 125 108 120
Age (yr, mean ± SD) 67.3 ± 8.6 67.8 ± 10.1 67.3 ± 8.5 67.5 ± 10.2 NS NS
< 60 21 21 18 21 NS NS
60-69 42 44 37 42
≥ 70 61 60 53 57
Male 69 83 64 80 NS NS
Female 55 42 44 40
Body mass index (kg/m2, mean ± SD) 22.5 ± 2.9 22.6 ± 2.7 22.7 ± 2.9 22.7 ± 2.6 NS NS
Bowel movements per week
< 2 16 5 0 0 < 0.05 NS
≥ 2 108 120 108 120
Previous colonoscopy
None (first time) 38 27 32 26 NS NS
≥ 2 86 98 76 94

P value by the χ2 test. NS: Not significant.